Literature DB >> 25143864

A pilot study in epilepsy patients using simultaneous PET/MR.

Yu-Shin Ding1, Bang-Bin Chen2, Christopher Glielmi3, Kent Friedman4, Orrin Devinsky5.   

Abstract

Integrated PET/MR with simultaneous acquisition may improve the identification of pathologic findings in patients. This pilot study evaluated metabolic activity differences between epilepsy patients and healthy controls and directly correlated FDG uptake with MR regional abnormality. Epilepsy patients (n=11) and controls (n=6) were imaged on a whole-body simultaneous PET/MR scanner. After FDG injection, simultaneous images were acquired for 60 minutes. Statistical analyses on SUV values (over 117 brain regions, including left and right, for 96 cortical and 21 subcortical regions) derived from three normalization methods, by individual subject's mean cortical, white matter or global brain, were compared between groups. The asymmetry was compared. T2, T1 and PET co-registered images were also used for lesion detection and correlation of PET and MR regional abnormality. Left and right postcentral gyri were found to be consistently hypermetabolic regions, while right temporal pole and planum polare were consistently hypometabolic regions by all three normalization methods. Using the asymmetry index (AI > 10% or SUV ratios > 1.2), more metabolic asymmetry regions were detected in patients than in controls, with 96.2% agreement. The presence of hippocampal abnormalities or cortical tubers detected via T2 FLAIR in patients correlated well with the hypometabolism detected via FDG-PET. Our results showed specific patterns of metabolic abnormality and asymmetry over 117 brain regions in epilepsy patients, as compared to controls, suggest that simultaneous PET/MR imaging provides a useful tool to help understand etiopathogenesis and localize seizure foci.

Entities:  

Keywords:  Epilepsy; FDG; asymmetry; hypermetabolism; hypometabolism; simultaneous PET/MR

Year:  2014        PMID: 25143864      PMCID: PMC4138140     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  49 in total

1.  Correlation of ventricular asymmetry with metabolic asymmetry in frontotemporal dementia.

Authors:  Y Jeong; Y M Song; P W Chung; E J Kim; S J Kang; J M Kim; S S Cho; S E Kim; H S Byun; D L Na
Journal:  J Neuroradiol       Date:  2005-09       Impact factor: 3.447

Review 2.  The tuberous sclerosis complex.

Authors:  Peter B Crino; Katherine L Nathanson; Elizabeth Petri Henske
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

3.  Transient focal cortical increase of interictal glucose metabolism in Sturge-Weber syndrome: implications for epileptogenesis.

Authors:  Bálint Alkonyi; Harry T Chugani; Csaba Juhász
Journal:  Epilepsia       Date:  2011-04-11       Impact factor: 5.864

4.  Age-dependent consequences of seizures and the development of temporal lobe epilepsy in the rat.

Authors:  C Dubé; M J da Silva Fernandes; A Nehlig
Journal:  Dev Neurosci       Date:  2001       Impact factor: 2.984

5.  FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome.

Authors:  W H Theodore; S Sato; C V Kufta; W D Gaillard; K Kelley
Journal:  Epilepsia       Date:  1997-01       Impact factor: 5.864

6.  Planned ictal FDG PET imaging for localization of extratemporal epileptic foci.

Authors:  C C Meltzer; P D Adelson; R P Brenner; P K Crumrine; A Van Cott; D P Schiff; D W Townsend; M L Scheuer
Journal:  Epilepsia       Date:  2000-02       Impact factor: 5.864

7.  Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM.

Authors:  Yu Kyeong Kim; Dong Soo Lee; Sang Kun Lee; Seok-Ki Kim; Chun Kee Chung; Ki Hyun Chang; Ki Young Choi; June-Key Chung; Myung Chul Lee
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

8.  Interictal spiking increases 2-deoxy[14C]glucose uptake and c-fos-like reactivity.

Authors:  A Handforth; D M Finch; R Peters; A M Tan; D M Treiman
Journal:  Ann Neurol       Date:  1994-06       Impact factor: 10.422

9.  The functional anatomy of limbic status epilepticus in the rat. I. Patterns of 14C-2-deoxyglucose uptake and Fos immunocytochemistry.

Authors:  L E White; J L Price
Journal:  J Neurosci       Date:  1993-11       Impact factor: 6.167

10.  Progressive metabolic changes underlying the chronic reorganization of brain circuits during the silent phase of the lithium-pilocarpine model of epilepsy in the immature and adult Rat.

Authors:  C Dubé; S Boyet; C Marescaux; A Nehlig
Journal:  Exp Neurol       Date:  2000-03       Impact factor: 5.330

View more
  11 in total

Review 1.  Hybrid MR-PET in Neuroimaging.

Authors:  S Bisdas; C Lá Fougere; U Ernemann
Journal:  Clin Neuroradiol       Date:  2015-07-31       Impact factor: 3.649

Review 2.  PET/MRI of central nervous system: current status and future perspective.

Authors:  Zhen Lu Yang; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2016-01-15       Impact factor: 5.315

Review 3.  Neuroimaging of epilepsy.

Authors:  Fernando Cendes; William H Theodore; Benjamin H Brinkmann; Vlastimil Sulc; Gregory D Cascino
Journal:  Handb Clin Neurol       Date:  2016

4.  Summary of the First ISMRM-SNMMI Workshop on PET/MRI: Applications and Limitations.

Authors:  Thomas A Hope; Zahi A Fayad; Kathryn J Fowler; Dawn Holley; Andrei Iagaru; Alan B McMillan; Patrick Veit-Haiback; Robert J Witte; Greg Zaharchuk; Ciprian Catana
Journal:  J Nucl Med       Date:  2019-05-23       Impact factor: 10.057

5.  Efficacy of delayed 18F-FDG hybrid PET/MRI for epileptic focus identification: a prospective cohort study.

Authors:  Fang Liu; Weiwei Ruan; Xuejun Deng; Yangmeihui Song; Wenyu Song; Fan Hu; Jinxia Guo; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-25       Impact factor: 9.236

Review 6.  Neurologic Applications of PET/MR Imaging.

Authors:  Michelle M Miller-Thomas; Tammie L S Benzinger
Journal:  Magn Reson Imaging Clin N Am       Date:  2017-01-26       Impact factor: 2.266

7.  Comparison of Qualitative and Quantitative Analyses of MR-Arterial Spin Labeling Perfusion Data for the Assessment of Pediatric Patients with Focal Epilepsies.

Authors:  Domenico Tortora; Matteo Cataldi; Mariasavina Severino; Alessandro Consales; Mattia Pacetti; Costanza Parodi; Fiammetta Sertorio; Antonia Ramaglia; Erica Cognolato; Giulia Nobile; Margherita Mancardi; Giulia Prato; Laura Siri; Thea Giacomini; Pasquale Striano; Dario Arnaldi; Gianluca Piatelli; Andrea Rossi; Lino Nobili
Journal:  Diagnostics (Basel)       Date:  2022-03-25

Review 8.  Modulation of Glucose Availability and Effects of Hypo- and Hyperglycemia on Status Epilepticus: What We Do Not Know Yet?

Authors:  Igor Santana de Melo; Amanda Larissa Dias Pacheco; Yngrid Mickaelli Oliveira Dos Santos; Laura Mello Figueiredo; Dannyele Cynthia Santos Pimentel Nicacio; Leia Cardoso-Sousa; Marcelo Duzzioni; Daniel Leite Góes Gitaí; Cristiane Queixa Tilelli; Robinson Sabino-Silva; Olagide Wagner de Castro
Journal:  Mol Neurobiol       Date:  2020-09-25       Impact factor: 5.590

9.  International Veterinary Epilepsy Task Force recommendations for a veterinary epilepsy-specific MRI protocol.

Authors:  Clare Rusbridge; Sam Long; Jelena Jovanovik; Marjorie Milne; Mette Berendt; Sofie F M Bhatti; Luisa De Risio; Robyn G Farqhuar; Andrea Fischer; Kaspar Matiasek; Karen Muñana; Edward E Patterson; Akos Pakozdy; Jacques Penderis; Simon Platt; Michael Podell; Heidrun Potschka; Veronika M Stein; Andrea Tipold; Holger A Volk
Journal:  BMC Vet Res       Date:  2015-08-28       Impact factor: 2.741

10.  Cerebral metabolism and perfusion in MR-negative individuals with refractory focal epilepsy assessed by simultaneous acquisition of (18)F-FDG PET and arterial spin labeling.

Authors:  Ilaria Boscolo Galazzo; Maria Vittoria Mattoli; Francesca Benedetta Pizzini; Enrico De Vita; Anna Barnes; John S Duncan; Hans Rolf Jäger; Xavier Golay; Jamshed B Bomanji; Matthias Koepp; Ashley M Groves; Francesco Fraioli
Journal:  Neuroimage Clin       Date:  2016-04-12       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.